Francisco Javier
Escalada San Martín
Consultor Médico
Eli Lilly and Company
Indianapolis, EE. UU.Eli Lilly and Company-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes
Diabetes Therapy, Vol. 14, Núm. 11, pp. 1771-1784